These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7947993)

  • 21. Rat monoclonal antibodies to rabbit and human serum low-density lipoprotein.
    Gherardi E; Hutchings A; Galfre G; Bowyer DE
    Biochem J; 1988 May; 252(1):237-45. PubMed ID: 2458711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibodies against modified low-density lipoproteins and their complexes in blood of patients with various manifestations of atherosclerosis].
    Belik IV; Ivantsova AA; Mamedova ZE; Denisenko AD
    Biomed Khim; 2016 May; 62(4):471-5. PubMed ID: 27563003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating antibodies recognizing malondialdehyde-modified proteins in healthy subjects.
    Vay D; Parodi M; Rolla R; Mottaran E; Vidali M; Bellomo G; Albano E
    Free Radic Biol Med; 2001 Feb; 30(3):277-86. PubMed ID: 11165874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.
    Schiopu A; Bengtsson J; Söderberg I; Janciauskiene S; Lindgren S; Ares MP; Shah PK; Carlsson R; Nilsson J; Fredrikson GN
    Circulation; 2004 Oct; 110(14):2047-52. PubMed ID: 15451805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunoenzymatic procedure for human apo B-containing particles quantification using monoclonal antibodies.
    Bustos P; Calvo C; Ulloa N; Quiroga A; Sepulveda J
    Hybridoma; 1998 Aug; 17(4):395-401. PubMed ID: 9790075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appearance of cross linked proteins in human atheroma and rat pre-fibrotic liver detected by a new monoclonal antibody.
    Itabe H; Jimi S; Kamimura S; Suzuki K; Uesugi N; Imanaka T; Shijo H; Takano T
    Biochim Biophys Acta; 1998 Feb; 1406(1):28-39. PubMed ID: 9545523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studying low-density lipoprotein-monoclonal antibody complexes using dynamic laser light scattering and analytical ultracentrifugation.
    Gutierrez MM; Tsai SW; Phillips ML; Curtiss LK; Milne RW; Schumaker VN
    Biochemistry; 1999 Jan; 38(4):1284-92. PubMed ID: 9930989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to oxidized lipoproteins and their relationship to myocardial infarction.
    Ryan M; Owens D; Kilbride B; Collins P; Johnson A; Tomkin GH
    QJM; 1998 Jun; 91(6):411-5. PubMed ID: 9709459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution pattern of auto-antibodies against oxidized low-density lipoproteins in renal transplant recipients.
    Kandoussi AM; Glowacki F; Duriez P; Tacquet A; Fruchart JC; Noël C
    Nephron; 2001 Nov; 89(3):303-8. PubMed ID: 11598394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assay methods of modified lipoproteins in plasma.
    Yamaguchi Y; Kunitomo M; Haginaka J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Dec; 781(1-2):313-30. PubMed ID: 12450666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis.
    Zhou X; Caligiuri G; Hamsten A; Lefvert AK; Hansson GK
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):108-14. PubMed ID: 11145941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The level of malondialdehyde-modified LDL and LDL immune complexes in patients with rheumatoid arthritis.
    Wang J; Hu B; Meng Y; Zhang C; Li K; Hui C
    Clin Biochem; 2009 Sep; 42(13-14):1352-7. PubMed ID: 19501077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins.
    Slot MC; Theunissen R; van Paassen P; Damoiseaux JG; Tervaert JW;
    Clin Exp Immunol; 2007 Aug; 149(2):257-64. PubMed ID: 17521320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein modification by lipid peroxidation products: formation of malondialdehyde-derived N(epsilon)-(2-propenol)lysine in proteins.
    Uchida K; Sakai K; Itakura K; Osawa T; Toyokuni S
    Arch Biochem Biophys; 1997 Oct; 346(1):45-52. PubMed ID: 9328283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cultivation and Immortalization of Human B-Cells Producing a Human Monoclonal IgM Antibody Binding to MDA-LDL: Further Evidence for Formation of Atherogenic MDA-LDL Adducts in Humans
    Tatzber F; Pursch E; Resch U; Pfragner R; Holasek S; Lindschinger M; Cvirn G; Wonisch W
    Oxid Med Cell Longev; 2017; 2017():6047142. PubMed ID: 29250300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
    Krul ES; Tikkanen MJ; Cole TG; Davie JM; Schonfeld G
    J Clin Invest; 1985 Feb; 75(2):361-9. PubMed ID: 3973009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological detection of large oxidized lipoproteins in hypertriglyceridemic serum.
    Sakurai T; Wada N; Takahashi Y; Ichikawa A; Ikuta A; Furumaki H; Hui SP; Jin S; Takeda S; Fuda H; Fujikawa M; Shimizu C; Nagasaka H; Furukawa H; Kobayashi S; Chiba H
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):465-72. PubMed ID: 23858503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between triglyceride concentrations and LDL size evaluated by malondialdehyde-modified LDL.
    Kondo A; Muranaka Y; Ohta I; Notsu K; Manabe M; Kotani K; Saito K; Maekawa M; Kanno T
    Clin Chem; 2001 May; 47(5):893-900. PubMed ID: 11325894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses.
    Teng B; Sniderman A; Krauss RM; Kwiterovich PO; Milne RW; Marcel YL
    J Biol Chem; 1985 Apr; 260(8):5067-72. PubMed ID: 2580831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.